F1 demonstrates unique immunomodulatory properties through NK cell activation via IGF-1-dependent mechanisms [25], while Rg5 and Rk1 exhibit broad-spectrum cytotoxicity across multiple cancer types including breast cancer, cervical cancer, and hepatocellular carcinoma [114,193,194]. Here, IGF1 is linked to cancer.